follow up | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  9594 of 9884  at  3/15/2019 2:00:48 PM  by

moshes


follow up

Map seems right.
If post-NDS long term follow-up is required, then it makes sense to keep the same cohort that you used for filing. We know it worked well enough in these people, so it saves having to vet a new group. And since you are starting with people already on the drug, you get long term data earlier.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 161
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...